NYSE: ZEPPZepp Health Corp Stock
$2.56+0.00 (+0%)
Updated Apr 17, 2025
ZEPP Price
$2.56
Fair Value Price
N/A
Market Cap
$36.82M
52 Week Low
$2.06
52 Week High
$4.38
P/E
-0.56x
P/B
0.15x
P/S
0.23x
PEG
N/A
Dividend Yield
N/A
Revenue
$182.86M
Earnings
-$75.74M
Gross Margin
38.5%
Operating Margin
-30.89%
Profit Margin
-41.4%
Debt to Equity
1.1
Operating Cash Flow
N/A
Beta
1.05
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
ZEPP Overview
Zepp Health Corporation manufactures and sells smart wearable technological devices in China. It operates through two segments, Xiaomi Wearable Products and Self-Branded Products and Others. The company offers smart bands, watches, and accessories, as well as sportswear, home gyms, and treadmills under the Xiaomi and Amazfit brands. It allows users to monitor biometric data through its Mi Fit and Amazfit mobile apps. The company was founded in 2013 and is headquartered in Hefei, CN.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine ZEPP's potential to beat the market
- ZEPP doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Consumer Electronic
Industry Rating
D
ZEPP
RankedUnranked of 11
RankedUnranked of 11
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $4.98 | B | |
| $10.91 | C | |
| $4.60 | C |
Be the first to know about important ZEPP news, forecast changes, insider trades & much more!
ZEPP News
Overview
Due Diligence Score
–
Industry Average (24)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how ZEPP scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
ZEPP is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ZEPP is good value based on its book value relative to its share price (0.15x), compared to the US Consumer Electronics industry average (25.34x)
P/B vs Industry Valuation
ZEPP is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 35 more ZEPP due diligence checks available for Premium users.
Valuation
ZEPP price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.56x
Industry
30.54x
Market
27.98x
ZEPP price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.15x
Industry
25.34x
ZEPP is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
ZEPP's financial health
Profit margin
Revenue
$59.5M
Net Income
-$36.9M
Profit Margin
-61.9%
ZEPP's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$528.6M
Liabilities
$275.9M
Debt to equity
1.1
ZEPP's short-term assets ($251.56M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ZEPP's short-term assets ($251.56M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ZEPP's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
ZEPP's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
N/A
Investing
N/A
Financing
N/A
ZEPP vs Consumer Electronic Stocks
Zepp Health Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.